{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:07:31Z","timestamp":1791274051384,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RO1 CA138197"],"award-info":[{"award-number":["RO1 CA138197"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54 CA149196"],"award-info":[{"award-number":["U54 CA149196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006784","name":"Golfers Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Causes for a Cure"},{"name":"Team Tiara"},{"name":"Emily W. Herrman Cancer Research Laboratory"},{"name":"Komen for Cure","award":["KG 081694"],"award-info":[{"award-number":["KG 081694"]}]},{"name":"Komen for Cure","award":["R21CA179720"],"award-info":[{"award-number":["R21CA179720"]}]},{"name":"Komen for Cure","award":["R21CA173150"],"award-info":[{"award-number":["R21CA173150"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.canlet.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T09:17:00Z","timestamp":1459934220000},"page":"249-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair"],"prefix":"10.1016","volume":"376","author":[{"given":"Diana H.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Soon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe E.","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny A.","family":"Kaipparettu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2016.04.002_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1574887110666150624101343","article-title":"Role of carboplatin in the treatment of triple negative early-stage breast cancer","volume":"10","author":"Valsecchi","year":"2015","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.canlet.2016.04.002_bib0020","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2016.04.002_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humpath.2011.05.005","article-title":"CD44(+)\/CD24(\u2212\/low) cancer stem\/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome","volume":"43","author":"Idowu","year":"2012","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.canlet.2016.04.002_bib0030","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.04.002_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2938","article-title":"Epithelial-mesenchymal transition, cancer stem cells and treatment resistance","volume":"14","author":"Dave","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.002_bib0040","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.04.002_bib0045","doi-asserted-by":"crossref","first-page":"18115","DOI":"10.1073\/pnas.1006732107","article-title":"Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.04.002_bib0050","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1746","article-title":"Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1","volume":"32","author":"Choi","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2016.04.002_bib0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.18632\/genesandcancer.9","article-title":"Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells","volume":"5","author":"Zhang","year":"2014","journal-title":"Genes Cancer"},{"key":"10.1016\/j.canlet.2016.04.002_bib0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2012.05.030","article-title":"Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors","volume":"325","author":"Thomas","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.04.002_bib0065","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s11095-012-0753-1","article-title":"Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation","volume":"29","author":"Harhaji-Trajkovic","year":"2012","journal-title":"Pharm. Res"},{"key":"10.1016\/j.canlet.2016.04.002_bib0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(14)70160-3","article-title":"Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial","volume":"15","author":"von Minckwitz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canlet.2016.04.002_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.2014.57.0572","volume":"33","author":"Sikov","year":"2015","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2016.04.002_bib0080","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1158\/1078-0432.CCR-11-3326","article-title":"Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors","volume":"19","author":"Schott","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.002_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbabio.2009.07.008","article-title":"Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids","volume":"1797","author":"Ma","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2016.04.002_bib0090","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2010-08-299784","article-title":"Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1\/2 activation and Egr-1-mediated transcriptional events","volume":"118","author":"Kim","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2016.04.002_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-014-3051-2","article-title":"Metabolic differences in breast cancer stem cells and differentiated progeny","volume":"146","author":"Vlashi","year":"2014","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2016.04.002_bib0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/ars.2013.5229","article-title":"Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst","volume":"20","author":"Wu","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.canlet.2016.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.bbabio.2014.07.005","article-title":"Evidence of oxidative stress and mitochondrial respiratory chain dysfunction in an in vitro model of sepsis-induced kidney injury","volume":"1837","author":"Quoilin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2016.04.002_bib0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-33-14","article-title":"Clinical implications of high NQO1 expression in breast cancers","volume":"33","author":"Yang","year":"2014","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.002_bib0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-5793(95)00144-X","article-title":"Alterations in the internucleosomal DNA helical twist in chromatin of human erythroleukemia cells in vivo influences the chromatin higher-order folding","volume":"361","author":"Krajewski","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.canlet.2016.04.002_bib0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00216-011-5213-y","article-title":"Time-resolved chloroquine-induced relaxation of supercoiled plasmid DNA","volume":"402","author":"Mahut","year":"2012","journal-title":"Anal. Bioanal. Chem"},{"key":"10.1016\/j.canlet.2016.04.002_bib0125","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1111\/j.1742-4658.2005.04741.x","article-title":"Histone H2A phosphorylation in DNA double-strand break repair","volume":"272","author":"Foster","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2016.04.002_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fchem.2015.00035","article-title":"Stress-induced DNA damage biomarkers: applications and limitations","volume":"3","author":"Nikitaki","year":"2015","journal-title":"Front Chem"},{"key":"10.1016\/j.canlet.2016.04.002_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11912-014-0428-7","article-title":"Assessing the role of platinum agents in aggressive breast cancers","volume":"17","author":"Sikov","year":"2015","journal-title":"Curr. Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.04.002_bib0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.canlet.2016.04.002_bib0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1389201023378265","article-title":"Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress","volume":"3","author":"Decker","year":"2002","journal-title":"Curr. Pharm. Biotechnol"},{"key":"10.1016\/j.canlet.2016.04.002_bib0150","doi-asserted-by":"crossref","first-page":"425708","DOI":"10.1155\/2015\/425708","article-title":"Antioxidant mechanisms and ROS-related MicroRNAs in cancer stem cells","volume":"2015","author":"Dando","year":"2015","journal-title":"Oxid. Med. Cell. Longev"},{"key":"10.1016\/j.canlet.2016.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/ars.2012.4529","article-title":"Reactive oxygen species in cancer stem cells","volume":"16","author":"Shi","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.canlet.2016.04.002_bib0160","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.04.002_bib0165","doi-asserted-by":"crossref","first-page":"37813","DOI":"10.1074\/jbc.M110.200675","article-title":"Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species","volume":"286","author":"Achuthan","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.04.002_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105724","article-title":"Evolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancers","volume":"9","author":"Yamamoto","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.04.002_bib0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.04.002_bib0180","doi-asserted-by":"crossref","first-page":"26560","DOI":"10.18632\/oncotarget.5306","article-title":"Triple negative breast cancer: looking for the missing link between biology and treatments","volume":"6","author":"Palma","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.04.002_bib0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10549-014-3033-4","article-title":"Platinum-based chemotherapy in triple-negative advanced breast cancer","volume":"146","author":"Villarreal-Garza","year":"2014","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2016.04.002_bib0190","article-title":"Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.04.002_bib0195","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516302154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516302154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T06:52:44Z","timestamp":1600411964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516302154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0304383516302154"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.04.002","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}